Fingerprint
Dive into the research topics of 'Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically